Lantus Sales Data
| Rank 16 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Lantus U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 16 ( 1) |
$675,461 | 5.84% | 4,534 | -4.37% |
| Q3 2013 | 17 (1) |
$638,181 | 6.49% | 4,741 | -14.42% |
| Q2 2013 | 18 | $599,306 | 1.18% | 5,540 | -4.32% |
| Q1 2013 | 18 ( 1) |
$592,333 | -1.17% | 5,790 | -9.19% |
| Q4 2012 | 17 | $599,359 | 7.77% | 6,376 | 5.69% |
| Q3 2012 | 17 (7) |
$556,147 | 4.94% | 6,033 | 4.34% |
| Q2 2012 | 24 | $529,983 | 1.81% | 5,782 | -1.72% |
| Q1 2012 | 24 (3) |
$520,584 | 9.78% | 5,883 | -0.08% |
| Q4 2011 | 27 (1) |
$474,189 | 0.69% | 5,888 | -1.09% |
| Q3 2011 | 26 | $470,948 | -3.61% | 5,953 | -1.70% |
| Q2 2011 | 26 (2) |
$488,609 | -3.90% | 6,056 | -2.51% |
| Q1 2011 | 24 | $508,416 | n/a | 6,212 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
